Clinical Trial

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 25, 2025 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Trial Details
NCT Number NCT07140640
Lead Sponsor Aswan University
Conditions Cesarean Section Complications
Enrollment 333 participants
Start Date 2025-09-15
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-25